Emerson Electric (EMR) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jul, 2026Executive summary
Announced proposal to acquire remaining AspenTech shares for $240/share in cash, aiming to fully integrate AspenTech and accelerate software-defined automation strategy.
Achieved strong operational performance in FY2024, with sales of $17.5B and adjusted segment EBITA margin of 26.0%.
Fiscal 2024 saw record adjusted EPS of $5.49, strong cash generation, and significant progress on portfolio transformation and Test & Measurement integration.
Initiated review of strategic alternatives, including a potential cash sale, for the Safety & Productivity business, which represents 8% of 2024 revenue.
Strategic actions announced mark the final phase of transformation into an industrial technology leader focused on advanced automation solutions.
Financial highlights
FY2024 underlying sales grew 6% year-over-year to $17.49B; adjusted EPS reached $5.49, up 24% from 2023.
Free cash flow was $2.9B, up 23% year-over-year, with a margin of 16.6%.
Adjusted segment EBITA margin was 26.0% for FY24 and 26.2% in Q4.
Test & Measurement contributed $0.45 to EPS, AspenTech $0.35.
Gross margin reached a record 50.8%, up nearly 1,000 bps from 2021.
Outlook and guidance
FY2025 underlying sales expected to grow 3%-5%; adjusted EPS guidance is $5.85-$6.05.
Free cash flow projected at $3.2B-$3.3B; $2B share repurchase and $1.2B dividend planned for 2025.
Q1 FY25 net sales growth expected at 2.5%-3.5%, adjusted EPS $1.25–$1.30.
Process and hybrid markets expected to grow mid-single digits; discrete markets to recover in second half.
China expected to return to growth in H2 2025; North America and Europe to see low to mid-single digit growth.
Latest events from Emerson Electric
- Targeting $21B sales, 30% EBITA margin, $8.00 EPS, and $10B shareholder returns by 2028.EMR
Investor Update9 Jul 2026 - Q3 sales rose 11%, adjusted EPS up 11%, and Copeland exit boosted debt reduction plans.EMR
Q3 20248 Jul 2026 - Director elections, compensation, and auditor ratification passed; board declassification failed.EMR
AGM 20268 Jul 2026 - Q2 sales and EPS rose, led by Test & Measurement, with robust 2026 outlook and capital returns.EMR
Q2 202611 May 2026 - Q1 2026 delivered 4% sales growth, 6% EPS growth, and raised guidance on strong automation demand.EMR
Q1 202617 Apr 2026 - Order growth, AI-driven automation, and software rebound underpin strong long-term outlook.EMR
JPMorgan Industrials Conference 202617 Mar 2026 - AI-driven software growth and robust U.S. demand fuel strong performance and future outlook.EMR
Citi's Global Industrial Tech & Mobility Conference 202618 Feb 2026 - Strong order growth, innovation, and high margins drive a positive outlook and investor confidence.EMR
Barclays 43rd Annual Industrial Select Conference17 Feb 2026 - Record margins, 13% EPS growth, and robust cash flow with AspenTech deal pending.EMR
Q1 20259 Jan 2026